C-X-C Chemokine Receptor Type 4 (CXCR4) and Programmed Death-Ligand 1 (PD-L1) Expression are Prognostic Biomarkers for Papillary Thyroid Carcinoma

被引:0
|
作者
Ding, Ting [1 ]
Song, Qian [1 ]
Xu, Yanjun [2 ]
Liu, Qiya [3 ]
机构
[1] Huanggang Cent Hosp, Dept Endocrinol, Huanggang City 438021, Hubei, Peoples R China
[2] Zhejiang Univ Tradit Chinese Med, Dept Special Inspect Sect, Affiliated Hosp 3, Hangzhou 310014, Zhejiang, Peoples R China
[3] Sha He Hosp Chang Ping Dist Beijing, Dept Gen Med, Beijing 100005, Peoples R China
关键词
CXCR4; PD-L1; Papillary Thyroid Carcinoma; Survival Analysis; CANCER; SURVIVAL; NIVOLUMAB; ANTITUMOR; PATHWAY;
D O I
10.1166/jbt.2022.2987
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Chemokines and immunomodulatory factors involve in tumor development. Papillary thyroid carcinoma (PTC) is considered to start from dendritic cell infiltration and then produce immunomodulatory factors. In this study, CXCR4 and PD-L1 biomarkers were used to explore their prognostic role in PTC survival. Confocal microscopy detected the transfection efficiency in tumor cells. 42 PTC patients and thyroiditis patients (control) were enrolled to measure the expressions of CXCR4 and PD-L1. Multi-factor analysis analyzed the effect of combined CXCR4 and PD-L1 expression on ROC. The two groups had no differences in the baseline characteristics. CTXCR4 and PD-L1 level in PTC patients was significantly higher than control. CXCR4 was lowly expressed in thyroid cancer tissue and PD-L1 was highly expressed in serological samples. Compared with single measurement, the combined detection of CXCR4 and PD-L1 showed more ROC area. In conclusion, reduced CXCR4 and increased PD-L1 levelis found in thyroid cancer and their level might be used IP: 182.75.148.10 On: Thu, 20 Jan 2022 10:55:44 as predictive markers for PTtoCopyright:improve thAmeriancurative Scintificeffect. Publishers
引用
收藏
页码:953 / 957
页数:5
相关论文
共 50 条
  • [41] Bone Marrow Mesenchymal Stem Cell (BMSC) Restrains the Angiogenesis in Melanoma Through Stromal-Derived-Factor-1/C-X-C Chemokine Receptor Type 4 (SDF-1/CXCR4)
    Jiao, Liyan
    Yang, Qingyan
    Miao, Guoying
    Wang, Youming
    Yang, Zhitang
    Liu, Xiaojuan
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2022, 12 (10) : 2057 - 2062
  • [42] Production of human embryonic kidney 293T cells stably expressing C-X-C chemokine receptor type 4 (CXCR4) as a screening tool for anticancer lead compound targeting CXCR4
    Ha, Dinh Thi Thai
    Glab-ampai, Kittirat
    Rojsitthisak, Pornchai
    Vajragupta, Opa
    LIFE SCIENCES, 2022, 303
  • [43] Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimics
    Cassol, Clarissa A.
    Owen, Dwight
    Kendra, Kari
    Braga, Juarez R.
    Frankel, Wendy L.
    Arnold, Christina A.
    HISTOPATHOLOGY, 2020, 77 (02) : 240 - 249
  • [44] High expression of C-X-C chemokine receptor 4 and Notch1 is predictive of lymphovascular invasion and poor prognosis in lung adenocarcinoma
    Cong, Zhuangzhuang
    Wu, Haiwei
    Guo, Zhong
    Qin, Tao
    Xu, Yang
    Jing, Hua
    Wang, Yanqing
    Shen, Yi
    TUMOR BIOLOGY, 2017, 39 (06)
  • [45] Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas
    Kassardjian, Ari
    Shintaku, Peter I.
    Moatamed, Neda A.
    PLOS ONE, 2018, 13 (04):
  • [46] A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma
    Hu, Fei
    Miao, Lin
    Zhao, Yu
    Xiao, Yuan-Yuan
    Xu, Qing
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 3625 - 3633
  • [47] PD-L1 (22C3) expression and prognostic implications in esophageal squamous cell carcinoma
    Chi, Zhikai
    Peng, Lan
    Karamchandani, Dipti M.
    Xu, Jing
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2025, 74
  • [48] Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors
    Cierna, Z.
    Mego, M.
    Miskovska, V.
    Machalekova, K.
    Chovanec, M.
    Svetlovska, D.
    Hainova, K.
    Rejlekova, K.
    Macak, D.
    Spanik, S.
    Ondrus, D.
    Kajo, K.
    Mardiak, J.
    Babal, P.
    ANNALS OF ONCOLOGY, 2016, 27 (02) : 300 - 305
  • [49] Lack of specific alleles for the bovine chemokine (C-X-C) receptor type 4 (CXCR4) gene in West African cattle questions its role as a candidate for trypanotolerance
    Alvarez, Isabel
    Perez-Pardal, Lucia
    Traore, Amadou
    Fernandez, Ivan
    Goyache, Felix
    INFECTION GENETICS AND EVOLUTION, 2016, 42 : 30 - 33
  • [50] Programmed Death-Ligand 1 (PD-L1) Expression in Clinical Practice: Comparison of Temporally or Spatially Separated Test Results
    Deshpande, C.
    Patel, K.
    Litzky, L.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1820 - S1821